CN Patent

CN109867631A — 一种含有6-甲基尿嘧啶结构化合物的制备方法

Assigned to CHENGDA PHARMACEUTICALS CO LTD · Expires 2019-06-11 · 7y expired

What this patent protects

本发明涉及医药品中间体6‑甲基尿嘧啶衍生物的制备方法和应用。与现有技术相比，本申请用于合成医药活性分子具有以下益处：原子经济性好；反应收率高；后处理简单，除杂能力强，得到的产品纯度高。

USPTO Abstract

本发明涉及医药品中间体6‑甲基尿嘧啶衍生物的制备方法和应用。与现有技术相比，本申请用于合成医药活性分子具有以下益处：原子经济性好；反应收率高；后处理简单，除杂能力强，得到的产品纯度高。

Drugs covered by this patent

Patent Metadata

Patent number: CN109867631A
Jurisdiction: CN
Classification: —
Expires: 2019-06-11
Drug substance claim: No
Drug product claim: No
Assignee: CHENGDA PHARMACEUTICALS CO LTD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.